These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 23957430)

  • 1. Inflammatory myofibroblastic tumour of the lung with a novel PPFIBP1-ALK fusion variant.
    Yoshida A; Shibata T; Tsuta K; Watanabe S; Tsuda H
    Histopathology; 2013 Dec; 63(6):881-3. PubMed ID: 23957430
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary inflammatory myofibroblastic tumor expressing a novel fusion, PPFIBP1-ALK: reappraisal of anti-ALK immunohistochemistry as a tool for novel ALK fusion identification.
    Takeuchi K; Soda M; Togashi Y; Sugawara E; Hatano S; Asaka R; Okumura S; Nakagawa K; Mano H; Ishikawa Y
    Clin Cancer Res; 2011 May; 17(10):3341-8. PubMed ID: 21430068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cutaneous inflammatory myofibroblastic tumour with ALK rearrangement in the upper extremity.
    Cantile M; Aquino G; Franco R; Marra L; Gallo M; De Chiara A
    Pathology; 2014 Oct; 46(6):575-6. PubMed ID: 25158817
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of an inflammatory myofibroblastic tumor in the lung which expressed TPM3-ALK gene fusion.
    Kinoshita Y; Tajiri T; Ieiri S; Nagata K; Taguchi T; Suita S; Yamazaki K; Yoshino I; Maehara Y; Kohashi K; Yamamoto H; Oda Y; Tsuneyoshi M
    Pediatr Surg Int; 2007 Jun; 23(6):595-9. PubMed ID: 17063337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor.
    Panagopoulos I; Nilsson T; Domanski HA; Isaksson M; Lindblom P; Mertens F; Mandahl N
    Int J Cancer; 2006 Mar; 118(5):1181-6. PubMed ID: 16161041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FN1: a novel fusion partner of ALK in an inflammatory myofibroblastic tumor.
    Ouchi K; Miyachi M; Tsuma Y; Tsuchiya K; Iehara T; Konishi E; Yanagisawa A; Hosoi H
    Pediatr Blood Cancer; 2015 May; 62(5):909-11. PubMed ID: 25682942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult-onset inflammatory myofibroblastic tumour of the stomach with a TFG-ROS1 fusion.
    Fujita H; Yoshida A; Taniguchi H; Katai H; Sekine S
    Histopathology; 2015 Mar; 66(4):610-2. PubMed ID: 25293980
    [No Abstract]   [Full Text] [Related]  

  • 8. Inflammatory myofibroblastic tumour of the testis with confirmed anaplastic lymphoma kinase gene rearrangement.
    Hickman RA; Alexander M; Provet J; Melamed J; Deng FM
    Histopathology; 2016 Jun; 68(7):1109-11. PubMed ID: 26444540
    [No Abstract]   [Full Text] [Related]  

  • 9. ALK-ATIC fusion in urinary bladder inflammatory myofibroblastic tumor.
    Debiec-Rychter M; Marynen P; Hagemeijer A; Pauwels P
    Genes Chromosomes Cancer; 2003 Oct; 38(2):187-90. PubMed ID: 12939746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiplexed gene expression and fusion transcript analysis to detect ALK fusions in lung cancer.
    Lira ME; Kim TM; Huang D; Deng S; Koh Y; Jang B; Go H; Lee SH; Chung DH; Kim WH; Schoenmakers EF; Choi YL; Park K; Ahn JS; Sun JM; Ahn MJ; Kim DW; Mao M
    J Mol Diagn; 2013 Jan; 15(1):51-61. PubMed ID: 23246132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An inflammatory myofibroblastic tumor in liver with ALK and RANBP2 gene rearrangement: combination of distinct morphologic, immunohistochemical, and genetic features.
    Chen ST; Lee JC
    Hum Pathol; 2008 Dec; 39(12):1854-8. PubMed ID: 18701132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALK status in a primary lung tumour and metachronous metastases.
    Salido M; Pijuan L; Galván AB; Gimeno J; Cañadas I; Rodriguez-Rivera M; Rojo F; Albanell J; Solé F; Arriola E
    Histopathology; 2012 Apr; 60(5):843-5. PubMed ID: 22236334
    [No Abstract]   [Full Text] [Related]  

  • 13. Absence of human herpesvirus-8 and Epstein-Barr virus in inflammatory myofibroblastic tumor with anaplastic large cell lymphoma kinase fusion gene.
    Yamamoto H; Kohashi K; Oda Y; Tamiya S; Takahashi Y; Kinoshita Y; Ishizawa S; Kubota M; Tsuneyoshi M
    Pathol Int; 2006 Oct; 56(10):584-90. PubMed ID: 16984614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting anaplastic lymphoma kinase in lung cancer.
    Shaw AT; Solomon B
    Clin Cancer Res; 2011 Apr; 17(8):2081-6. PubMed ID: 21288922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant high-grade histological transformation of inflammatory myofibroblastic tumour associated with amplification of TPM3-ALK.
    Zhang H; Erickson-Johnson M; Wang X; Bahrami A; Medeiros F; Lonzo ML; Oliveira AM
    J Clin Pathol; 2010 Nov; 63(11):1040-1. PubMed ID: 20870660
    [No Abstract]   [Full Text] [Related]  

  • 16. Small non-mucinous bronchioloalveolar carcinoma with anaplastic lymphoma kinase immunoreactivity: a novel ALK fusion gene?
    Yamamoto M; Takeuchi K; Shimoji M; Maniwa T; Isaka M; Nakagawa K; Ohde Y; Kondo H; Nakajima T
    Cancer Sci; 2012 Feb; 103(2):390-2. PubMed ID: 22296236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically informed lung cancer medicine.
    Pao W; Iafrate AJ; Su Z
    J Pathol; 2011 Jan; 223(2):230-40. PubMed ID: 21125677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paracrine receptor activation by microenvironment triggers bypass survival signals and ALK inhibitor resistance in EML4-ALK lung cancer cells.
    Yamada T; Takeuchi S; Nakade J; Kita K; Nakagawa T; Nanjo S; Nakamura T; Matsumoto K; Soda M; Mano H; Uenaka T; Yano S
    Clin Cancer Res; 2012 Jul; 18(13):3592-602. PubMed ID: 22553343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory myofibroblastic tumour: a rare entity with wide differential diagnosis.
    Gilani SM; Kowalski PJ
    Pathologica; 2014 Mar; 106(1):1-6. PubMed ID: 24897773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelioid cell histiocytoma of the skin with clonal ALK gene rearrangement resulting in VCL-ALK and SQSTM1-ALK gene fusions.
    Jedrych J; Nikiforova M; Kennedy TF; Ho J
    Br J Dermatol; 2015; 172(5):1427-9. PubMed ID: 25413595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.